Assembly Bill A5068 proposes a comprehensive framework that integrates hemp-derived products into New Jersey’s hemp, cannabis, and public health oversight systems. It ensures consistency in testing, retail regulation, and enforcement for all hemp products.  Senate Bill S4509, while addressing some core issues such as licensing and certain intoxicating product prohibitions, omits critical measures on testing standards, product sourcing oversight, and protections for minors and medical patients.

A5068 reflects a comprehensive, thoughtful response to the real challenges facing the hemp and cannabis industries in New Jersey. It integrates consumer safety, business development, enforcement clarity, and access into an enforceable framework. S4509, in contrast, leaves significant gaps in oversight, enforcement, and product safety—permitting the continued sale of intoxicating and often unregulated hemp-derived products alongside licensed cannabis in regulated stores. This risks misleading consumers, undermines the integrity of New Jersey’s cannabis market, and puts public health and safety in jeopardy.

Please ask legislators to support A 5068 and oppose S4509.